ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹53 Cr | ₹43 Cr | ₹68 Cr | ₹53 Cr | ₹6.88 Cr |
What is the latest Total Non-Current Liabilities ratio of ALEMBIC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹53 Cr |
Mar2023 | ₹43 Cr |
Mar2022 | ₹68 Cr |
Mar2021 | ₹53 Cr |
Mar2020 | ₹6.88 Cr |
How is Total Non-Current Liabilities of ALEMBIC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹53 Cr | 23.76 | |
Mar2023 | ₹43 Cr | -36.78 | |
Mar2022 | ₹68 Cr | 28.72 | |
Mar2021 | ₹53 Cr | 663.25 | |
Mar2020 | ₹6.88 Cr | - |
Compare Total Non-Current Liabilities of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹2,767.0 Cr | 5.6% | 21% | 12% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,946.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹120,751.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,988.0 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,066.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | 5.6% |
21% |
12% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses